Bian maohong

Bian maohong


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
FJfang jian
fang jian
XGXuhui Ge
Xuhui Ge
WXWenjing Xu
Wenjing Xu
JXJingjing Xie
Jingjing Xie
ZQZhongke Qin
Zhongke Qin
HWHao Wang
Hao Wang

1 February 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
RXRufeng Xie
Rufeng Xie
YYYiming Yang
Yiming Yang
YZYueyue Zhu
Yueyue Zhu
LGLi Gao
Li Gao
XJXueyu Jiang
Xueyu Jiang
JYJie Yang
Jie Yang

30 November 2018 in Transfusion
Verified
Journal Article
Closed access
PDF file
RHRui He
Rui He
LLLing Li
Ling Li
YKYujie Kong
Yujie Kong
LTLi Tian
Li Tian
XTXue Tian
Xue Tian
ZLZhong Liu
Zhong Liu

10 February 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
FJFang Jian
Fang Jian
RYRen Yangyang
Ren Yangyang
XWXu Wei
Xu Wei
XJXu Jiadan
Xu Jiadan
LNLi Na
Li Na
ZPZhaoji Pan
Zhaoji Pan
Cerebellar degeneration-related protein 1 antisense (CDR1as) is an important member of the circRNAs family, also known as cirs-7. Its main function in vivo is to act as a mir-7 sponge. Accumulated studies show that CDR1as is closely related to various diseases, especially cancer. Our analysis show that CDR1as expression in human cancer is significantly associated with poor overall survival (hazard ratio [HR] = 2.50, 95% confidence interval [CI] = 2.06–3.04; p < 0.00001) and that high CDR1as expression is associated with the tumor node metastasis stage (odds ratio [OR] = 2.13, 95% CI = 1.63–2.78; p < 0.00001), and distant metastasis (OR = 3.50, 95% CI = 1.90–6.64; p < 0.00001). Furthermore, the results reveal the prognostic significance of CDR1as in neoplasms of the digestive system (HR = 1.69, 95% CI = 2.14–2.71; p < 0.001), colorectal cancer (HR = 1.34, 95% CI = 1.96–2.85; p < 0.001), and non-small cell lung cancer (HR = 2.40, 95% CI = 3.42–4.83; p = 0.008). In this study, we summarize in detail the latest research findings and demonstrate the function and regulatory mechanism of CDR1as in various cancer processes, and its potential as a biomarker for cancer prevention and prognosis.

1 March 2024 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YMYusheng Mao
Yusheng Mao
BZBangqiang Zhu
Bangqiang Zhu
HWHuiqin Wen
Huiqin Wen
TZTao Zhong
Tao Zhong
BMBian maohong
Bian maohong
Purpose: Ischemic stroke recurrence (ISR) is prevented by inhibiting platelet function. To investigate the impact of high on-treatment platelet reactivity (HTPR) assessed by thromboelastography (TEG) and its risk factors on ISR in individuals who have experienced acute ischemic stroke (AIS) receiving dual anti-platelet therapy (DAPT). Patients and Methods: At the end of follow-up, a total of 264 patients who met the criteria were enrolled in this cohort study. The primary endpoint event was a recurrence of ischemic stroke within 90 days of onset. Results: The ISR rate was 7.2% (19/264). The recurrence rate in the HTPR group was 15.1% (8/53), which was significantly higher than the 5.2% (11/211) in the non-HTPR group (p = 0.013), and the type 2 diabetes mellitus (T2DM) group (12.5%, 10/80) was also significantly higher compared to the non-T2DM group (4.9%, 9/184) (p = 0.028). T2DM was an isolated risk factor for HTPR (adjusted OR = 3.06, 95% CI 1.57– 5.98, P = 0.001). Kaplan-Meier plots showed that the cumulative risk (CR) of ISR was statistically different in the HTPR and T2DM groups compared to the non-HTPR group (log-rank P = 0.009) and the non-T2DM group (log-rank P = 0.026), respectively. The HTPR and T2DM groups had greater hazard ratios (HR) of ISR than the non-HTPR (adjusted HR = 2.78, 95% CI 1.06– 7.32, P = 0.038) and non-T2DM (adjusted HR = 2.64, 95% CI 1.01– 6.92, P = 0.049) groups. Conclusion: Both HTPR and T2DM are linked to ISR. Platelet Inhibition Rate (PIR) of TEG can early identify patients who are at high risk for having another ischemic stroke in patients undergoing DAPT, and this study may offer more evidence in favor of clinically personalized treatment and secondary prevention tactics.

13 August 2024 in Vox Sanguinis
Verified
Journal Article
Closed access
ZWZhe Wang
Zhe Wang
YCYushuang Chu
Yushuang Chu
YXYanlin Xiao
Yanlin Xiao
BMBian maohong
Bian maohong